![](../images/chemdb_main_product.jpg) |
![](../images/title_product_content.gif) |
|
|
|
Dasatinib|302962-49-8 |
![](../images/col_chem_composition.gif) |
99% |
![](../images/col_cas.gif) |
302962-49-8 |
![](../images/col_uses.gif) |
Leukemia
|
![](../images/col_property.gif) |
Dasatinib [CAS:302962-49-8]
Intermediates: 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide [CAS:302964-24-5] 2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide [CAS:302964-08-5] Usage:Leukemia
|
Industrial field |
pharmaceutical |
|
|
![](../images/product_title_com.gif) |
|
|
|
![](../images/box_com_top2.gif) |
There are no existing companies to distribute selected chemical product |
|
![](../images/box_com_bottom.gif) |
|
|
|